Company intelligence / Profile preview

Alexis Biochemicals

Lausen, Basel-Landschaft, Switzerland

Ownership: Private
Development stage: Other

Overview

Alexis Biochemicals was a prominent Swiss-based supplier of high-quality biochemical reagents and kits for the global life science research community. The company specialized in providing specialized tools for studying apoptosis, signal transduction, inflammation, and cancer biology. Known for its rigorous quality control and innovative product portfolio, Alexis offered a wide range of small molecules, antibodies, and proteins. In 2007, the company was integrated into Enzo Life Sciences following the acquisition of its parent company, Axxora Life Sciences, by Enzo Biochem.

Therapeutic areas: ImmunologyNeurologyOncology
Modalities: Small moleculeAntibodyRecombinant proteinBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Alexis Biochemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alexis Biochemicals.

Explore the full profile